GlycoMimetics, Inc.
HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS

Last updated:

Abstract:

Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, highly potent multimeric E-selectin antagonist are dessorbed and pharmaceutical compositions comprising at least one of the same.

Status:
Application
Type:

Utility

Filling date:

15 Jun 2021

Issue date:

21 Oct 2021